These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15771750)

  • 1. Review article: drugs interfering with visceral sensitivity for the treatment of functional gastrointestinal disorders--the clinical evidence.
    Kuiken SD; Tytgat GN; Boeckxstaens GE
    Aliment Pharmacol Ther; 2005 Mar; 21(6):633-51. PubMed ID: 15771750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity.
    Bueno L; de Ponti F; Fried M; Kullak-Ublick GA; Kwiatek MA; Pohl D; Quigley EM; Tack J; Talley NJ
    Neurogastroenterol Motil; 2007 Jan; 19(1 Suppl):89-119. PubMed ID: 17280587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in drug development for functional gastrointestinal disorders. Part II: visceral pain.
    Andresen V; Camilleri M
    Neurogastroenterol Motil; 2006 May; 18(5):354-60. PubMed ID: 16629862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs affecting visceral sensitivity: ready for the prime time?
    Delvaux MM; Gay G
    Dig Dis; 2006; 24(1-2):99-104. PubMed ID: 16699268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiological concepts of functional dyspepsia and irritable bowel syndrome future pharmacotherapy.
    Dobrek Ł; Thor PJ
    Acta Pol Pharm; 2009; 66(5):447-60. PubMed ID: 19894640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral hypersensitivity in functional disorders of the upper gastrointestinal tract.
    Sarnelli G; Vandenberghe J; Tack J
    Dig Liver Dis; 2004 Jun; 36(6):371-6. PubMed ID: 15248374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological and pharmacokinetic aspects of functional gastrointestinal disorders.
    Camilleri M; Bueno L; de Ponti F; Fioramonti J; Lydiard RB; Tack J
    Gastroenterology; 2006 Apr; 130(5):1421-34. PubMed ID: 16678556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gastrointestinal motility disorders and drugs: cholinergic, anticholinergic, adrenergic, antiadrenergic and prokinetic drugs (part I)].
    Jovanović-Mićić D; Janković S; Beleslin DB
    Srp Arh Celok Lek; 1994; 122(1-2):50-4. PubMed ID: 17972806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological treatment of irritable bowel syndrome--from concept to sales.
    Kamm MA
    Eur J Surg Suppl; 2002; (587):10-5. PubMed ID: 16144196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic referral of visceral sensations and rectal sensory threshold for pain in children with functional gastrointestinal disorders.
    Faure C; Wieckowska A
    J Pediatr; 2007 Jan; 150(1):66-71. PubMed ID: 17188617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is visceral hypersensitivity correlated with symptom severity in children with functional gastrointestinal disorders?
    Castilloux J; Noble A; Faure C
    J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):272-8. PubMed ID: 18376243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gastrointestinal motility disorders and drugs: opioids, calcium antagonists, nitrates, peptides, prostaglandins and 5-hydroxytryptaminergic drugs (part II)].
    Jovanović-Mićić D; Samardzić R; Beleslin B
    Srp Arh Celok Lek; 1994; 122(3-4):88-92. PubMed ID: 17972818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT receptors and visceral hypersensitivity - 2B or not 2B, that is the question?
    Grundy D
    Neurogastroenterol Motil; 2006 May; 18(5):339-42. PubMed ID: 16629859
    [No Abstract]   [Full Text] [Related]  

  • 16. Review article: The rationale for antidepressant therapy in functional gastrointestinal disorders.
    Castle MZ; Silk DB; Libby GW
    Aliment Pharmacol Ther; 2004 May; 19(9):969-79. PubMed ID: 15113363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: The role of serotonergic agents in the treatment of patients with primary chronic constipation.
    Cash BD; Chey WD
    Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1047-60. PubMed ID: 16305718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond tricyclics: new ideas for treating patients with painful and refractory functional gastrointestinal symptoms.
    Drossman DA
    Am J Gastroenterol; 2009 Dec; 104(12):2897-902. PubMed ID: 19956115
    [No Abstract]   [Full Text] [Related]  

  • 19. Review article: current and emerging therapies for functional dyspepsia.
    Saad RJ; Chey WD
    Aliment Pharmacol Ther; 2006 Aug; 24(3):475-92. PubMed ID: 16886913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing of visceral sensitivity.
    Mulak A
    J Physiol Pharmacol; 2003 Dec; 54 Suppl 4():55-72. PubMed ID: 15075449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.